Health Care Sector Update for 12/12/2014: JAZZ,CCXI,EPRS

Top Health Care Stocks JNJ -1.22% PFE -1.72% ABT -0.34% MRK -1.61% AMGN +0.37% Health care stocks were broadly lower, with the NYSE Health Care Sector Index declining about 1.1% and shares of health care companies in the S&P 500 slipping about 0.8% as a group. In company news, Jazz Pharmaceuticals ( JAZZ ) fell Friday despite the drugmaker’s saying it has initiated a rolling submission of a new drug application with U.S. regulators for its defibrotide drug candidate as a treatment of severe hepatic veno-occlusive disease in patients undergoing hematopoietic stem-cell transplantation therapy.



Sources Are Here

(1) Health Care Sector Update for 12/12/2014: JAZZ,CCXI,EPRS
URL: http://ri.search.yahoo.com/_ylt=AwrBEiL3xYtUVA0AzhL_wgt./RV=2/RE=1418475127/RO=10/RU=http://www.nasdaq.com/article/health-care-sector-update-for-12122014-jazzccxieprs-cm422794/RK=0/RS=wuhIUNmmlQ5hF7oiZsK0EPf6HLo-


Abnormal properties of cancer protein revealed in fly eyes

Mutations in the human retinoblastoma protein gene are a leading cause of eye cancer. Now, Michigan State University scientists have turned to fruit fly eyes to unlock the secrets of this important cancer gene. In a paper featured on the cover of the current issue of the Journal of Biological Chemistry, Michigan State University researchers provide the first detailed examination of a set of mutations similar to those present in the human cancer gene, said Irina Pushel, MSU undergraduate and co-author



Sources Are Here

(1) Abnormal properties of cancer protein revealed in fly eyes
URL: http://ri.search.yahoo.com/_ylt=AwrBEiQAUBxUQBMAcY7_wgt./RV=2/RE=1411170433/RO=10/RU=http://www.sciencedaily.com/releases/2014/09/140917121005.htm/RK=0/RS=o1Hb2cTwijlR8rFbyUu2yEqp2G8-


Artificial intelligence, big data and harnessing the bodys hidden drugs

Inside Bergs labs. Courtesy of Berg



Sources Are Here

(1) Artificial intelligence, big data and harnessing the bodys hidden drugs
URL: http://ri.search.yahoo.com/_ylt=AwrBJSAUiANUJAgACCr_wgt./RV=2/RE=1409546388/RO=10/RU=http://medcitynews.com/2014/08/artificial-intelligence-big-data-harnessing-bodys-hidden-drugs//RK=0/RS=3M4XVExz3_QoJ_PUKdRZjSiW77k-


Consumer Reports: Your guide to the new insurance rules

The new health care law has improved a lot of things about health insurance, according to Consumer Reports. You can’t be turned down or charged extra if you have a pre-existing condition, all types of basic health services are covered, plans can’t cap annual or lifetime benefits and most preventive care is free



Sources Are Here

(1) Consumer Reports: Your guide to the new insurance rules
URL: http://ri.search.yahoo.com/_ylt=AwrBJSC031xTXX0A_pz_wgt./RV=2/RE=1398624309/RO=10/RU=http://www.courant.com/business/custom/consumer/hc-ls-consumer-reports-insurance-20140426,0,6487933.story?track=rss/RK=0/RS=fvC2JNct8sTi9YdgxusX.UdlQwk-


Nanotechnology needs standards

Reading the pagesof theMaterials Today website you cannot help but notice the number of times nanotechnology is mentioned, it could be concerning a new drug that might one day cure Cancer or in a new electronic device that might tell us if there is life on Mars. Surprisingly though, nanotechnology is still not completely understood by many including Governments and economic leaders who would benefit from clear position statements, guidelines andstandards outlining the responsible use of nanomaterials in today’s society



Sources Are Here

(1) Nanotechnology needs standards
URL: http://ri.search.yahoo.com/_ylt=AwrBEiEqzBBTNWcAqZr_wgt./RV=2/RE=1393638570/RO=10/RU=http://www.materialstoday.com/nanomaterials/comment/nanotechnology-needs-standards//RK=0/RS=dLg2PQJXaOWH6nDCFT8EcUHeUsI-


EU regulator backs Bayer, GSK drugs, knocks back Novartis, Teva

* European Medicine Agency backs Bayer's Adempas * Knocks back Teva's Nerventra and Novartis' serelaxin LONDON, Jan 24 (Reuters) – Europe's drugs regulator gave its backing on Friday for marketing approval to be granted for Bayer's pulmonary hypertension drug Adempas and for GlaxoSmithKline's diabetes medicine Eperzan. The European Medicine Agency (EMA) also backed a new drug from Dainippon …



Sources Are Here

(1) EU regulator backs Bayer, GSK drugs, knocks back Novartis, Teva
URL: http://finance.yahoo.com/news/eu-regulator-backs-bayer-gsk-124116415.html;_ylt=A2KJ3CazF.NS3ywA8WH_wgt.


House Season 2 Episode 12 – Distractions – Video




House Season 2 Episode 12 – Distractions watchhouseseries.com While a severely burned teenager is admitted and his blood tests come back with strange results, House makes himself the guinea pig in his own unofficial tests of a new drug designed to treat migraines to prove a former medical school colleague is wrong about the drug. House s02e12 House S2e12 s02e12 S2e12 2×12 Season 2 episode 12 tv shows S2 s02 se2 e12 ep12 2×12 4 S02 E12 HQ episodes serie series watch online complete full tv television hd hq part 1 part 2 part 3 part 4. Watch House Season 2 Episode 12 Distractions watch online watch House Season 2 Episode 12 Distractions for free watch House Season 2 Episode 12 Distractions full free watch House Season 2 Episode 12 Distractions full episode online watch House Season 2 Episode 12 Distractions full episode watch full House Season 2 Episode 12 Distractions watch House Season 2 Episode 12 Distractions free online.From:ona broellTRViews:0 0ratingsTime:08:44More inPeople Blogs

Sources Are Here

(1) House Season 2 Episode 12 - Distractions - Video
URL: http://www.youtube.com/watch?v=ZvUD8BO2-7Y


Health Care is Going Mobile, Consumers Ready, Doctors Sill Leery

Got a cold, a weight problem or pain that wont go away? Theres an app for that.



Sources Are Here

(1) Health Care is Going Mobile, Consumers Ready, Doctors Sill Leery
URL: http://www.foxbusiness.com/personal-finance/2012/06/19/health-care-is-going-mobile-consumers-ready-doctors-sill-leery/


Nanotechnology for Drug Delivery: Global Market for Nanocrystals

NEW YORK, May 23, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Nanotechnology for Drug Delivery: Global Market for Nanocrystals http://www.reportlinker.com/p0799333/Nanotechnology-for-Drug-Delivery-Global-Market-for-Nanocrystals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology Nanocrystals will account for 60% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively



Sources Are Here

(1) Nanotechnology for Drug Delivery: Global Market for Nanocrystals
URL: http://finance.yahoo.com/news/nanotechnology-drug-delivery-global-market-105700643.html;_ylt=A2KJNTtax7xPFmUA3Uf_wgt.